Zimmer Biomet To Stop Selling CPT Hip Implant System By End Of 2024 Due To High Fracture Risks
Zimmer Biomet Holdings, Inc (NYSE:ZBH) announced plans to phase out its CPT Hip System by December. The decision comes on the ...
Nasdaq27d
Are Wall Street Analysts Predicting Zimmer Biomet Stock Will Climb or Sink?
Weak demand, ERP system disruptions, and market share losses in hip implants have propelled the stock downward over the past year. On Feb. 6, Zimmer Biomet reported its Q4 and full-year 2024 results.